VanEck Associates’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-179,488
| Closed | -$33M | – | 1332 |
|
|
2021
Q2 | $33M | Buy |
179,488
+4,396
| +3% | +$755K | 0.08% | 200 |
|
|
2021
Q1 | $26.8M | Sell |
175,092
-24,714
| -12% | -$3.82M | 0.07% | 199 |
|
|
2020
Q4 | $31.2M | Buy |
199,806
+13,215
| +7% | +$1.7M | 0.09% | 172 |
|
|
2020
Q3 | $21.4M | Sell |
186,591
-1,691
| -0.9% | -$182K | 0.07% | 175 |
|
|
2020
Q2 | $21.1M | Buy |
188,282
+20,058
| +12% | +$2.13M | 0.07% | 174 |
|
|
2020
Q1 | $15.1M | Buy |
168,224
+20,862
| +14% | +$2.05M | 0.08% | 166 |
|
|
2019
Q4 | $15.9M | Buy |
147,362
+10,960
| +8% | +$1.17M | 0.06% | 198 |
|
|
2019
Q3 | $13.4M | Buy |
136,402
+5,437
| +4% | +$613K | 0.06% | 190 |
|
|
2019
Q2 | $17.2M | Sell |
130,965
-8,081
| -6% | -$1.04M | 0.08% | 179 |
|
|
2019
Q1 | $18.8M | Sell |
139,046
-15,165
| -10% | -$1.89M | 0.09% | 167 |
|
|
2018
Q4 | $15M | Sell |
154,211
-20,379
| -12% | -$2.41M | 0.08% | 193 |
|
|
2018
Q3 | $24.3M | Buy |
174,590
+22,645
| +15% | +$2.84M | 0.12% | 157 |
|
|
2018
Q2 | $18.9M | Sell |
151,945
-20,111
| -12% | -$2.35M | 0.09% | 180 |
|
|
2018
Q1 | $19.2M | Sell |
172,056
-66,585
| -28% | -$7.96M | 0.1% | 172 |
|
|
2017
Q4 | $28.5M | Buy |
238,641
+14,222
| +6% | +$1.73M | 0.14% | 150 |
|
|
2017
Q3 | $31.5M | Sell |
224,419
-59,707
| -21% | -$8.11M | 0.16% | 135 |
|
|
2017
Q2 | $34.6M | Buy |
284,126
+40,408
| +17% | +$4.7M | 0.19% | 95 |
|
|
2017
Q1 | $29.5M | Buy |
243,718
+39,075
| +19% | +$5.04M | 0.13% | 130 |
|
|
2016
Q4 | $25M | Sell |
204,643
-10,750
| -5% | -$1.32M | 0.12% | 120 |
|
|
2016
Q3 | $26.4M | Buy |
215,393
+40,759
| +23% | +$5.25M | 0.12% | 109 |
|
|
2016
Q2 | $20.4M | Buy |
174,634
+12,422
| +8% | +$1.76M | 0.1% | 112 |
|
|
2016
Q1 | $22.6M | Sell |
162,212
-22,164
| -12% | -$3.25M | 0.15% | 117 |
|
|
2015
Q4 | $35.2M | Sell |
184,376
-6,587
| -3% | -$1.15M | 0.28% | 86 |
|
|
2015
Q3 | $29.9M | Sell |
190,963
-72,678
| -28% | -$13.3M | 0.23% | 104 |
|
|
2015
Q2 | $47.7M | Buy |
263,641
+70,595
| +37% | +$12.2M | 0.28% | 90 |
|
|
2015
Q1 | $33.5M | Buy |
193,046
+25,361
| +15% | +$4.59M | 0.19% | 114 |
|
|
2014
Q4 | $31M | Buy |
167,685
+3,306
| +2% | +$613K | 0.19% | 109 |
|
|
2014
Q3 | $27.3M | Buy |
164,379
+16,272
| +11% | +$2.67M | 0.14% | 129 |
|
|
2014
Q2 | $23.1M | Sell |
148,107
-31,533
| -18% | -$4.98M | 0.11% | 134 |
|
|
2014
Q1 | $27.3M | Sell |
179,640
-4,723
| -3% | -$751K | 0.14% | 124 |
|
|
2013
Q4 | $24.5M | Sell |
184,363
-3,006
| -2% | -$361K | 0.12% | 125 |
|
|
2013
Q3 | $21.8M | Buy |
187,369
+29,451
| +19% | +$3.23M | 0.11% | 106 |
|
|
2013
Q2 | $14.6M | Buy |
+157,918
| New | +$15.2M | 0.08% | 120 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM